These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 29989002)

  • 1. An Exome-wide Association Study for Type 2 Diabetes-Attributed End-Stage Kidney Disease in African Americans.
    Guan M; Keaton JM; Dimitrov L; Hicks PJ; Xu J; Palmer ND; Wilson JG; Freedman BI; Bowden DW; Ng MCY
    Kidney Int Rep; 2018 Jul; 3(4):867-878. PubMed ID: 29989002
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The ras responsive transcription factor RREB1 is a novel candidate gene for type 2 diabetes associated end-stage kidney disease.
    Bonomo JA; Guan M; Ng MC; Palmer ND; Hicks PJ; Keaton JM; Lea JP; Langefeld CD; Freedman BI; Bowden DW
    Hum Mol Genet; 2014 Dec; 23(24):6441-7. PubMed ID: 25027322
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genome-wide association study identifies novel loci for type 2 diabetes-attributed end-stage kidney disease in African Americans.
    Guan M; Keaton JM; Dimitrov L; Hicks PJ; Xu J; Palmer ND; Ma L; Das SK; Chen YI; Coresh J; Fornage M; Franceschini N; Kramer H; Langefeld CD; Mychaleckyj JC; Parekh RS; Post WS; Rasmussen-Torvik LJ; Rich SS; Rotter JI; Sedor JR; Thornley-Brown D; Tin A; Wilson JG; Freedman BI; Bowden DW; Ng MCY;
    Hum Genomics; 2019 May; 13(1):21. PubMed ID: 31092297
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of kidney structure-related gene variants with type 2 diabetes-attributed end-stage kidney disease in African Americans.
    Guan M; Ma J; Keaton JM; Dimitrov L; Mudgal P; Stromberg M; Bonomo JA; Hicks PJ; Freedman BI; Bowden DW; Ng MC
    Hum Genet; 2016 Nov; 135(11):1251-1262. PubMed ID: 27461219
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of coding variants identified from exome sequencing resources for association with diabetic and non-diabetic nephropathy in African Americans.
    Bailey JNC; Palmer ND; Ng MCY; Bonomo JA; Hicks PJ; Hester JM; Langefeld CD; Freedman BI; Bowden DW
    Hum Genet; 2014 Jun; 133(6):769-779. PubMed ID: 24385048
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association Analysis of the Reticulon 1 Gene in End-Stage Kidney Disease.
    Bonomo JA; Palmer ND; He JC; Fan Y; Hicks PJ; Lea JP; Okusa MD; Bowden DW; Freedman BI
    Am J Nephrol; 2015; 42(4):259-64. PubMed ID: 26496126
    [TBL] [Abstract][Full Text] [Related]  

  • 7.
    Chaudhary NS; Armstrong ND; Hidalgo BA; Gutiérrez OM; Hellwege JN; Limdi NA; Reynolds RJ; Judd SE; Nadkarni GN; Lange L; Winkler CA; Kopp JB; Arnett DK; Tiwari HK; Irvin MR
    Front Med (Lausanne); 2022; 9():971297. PubMed ID: 36250097
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Complement factor H gene associations with end-stage kidney disease in African Americans.
    Bonomo JA; Palmer ND; Hicks PJ; Lea JP; Okusa MD; Langefeld CD; Bowden DW; Freedman BI
    Nephrol Dial Transplant; 2014 Jul; 29(7):1409-14. PubMed ID: 24586071
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coding variants in nephrin (NPHS1) and susceptibility to nephropathy in African Americans.
    Bonomo JA; Ng MC; Palmer ND; Keaton JM; Larsen CP; Hicks PJ; ; Langefeld CD; Freedman BI; Bowden DW
    Clin J Am Soc Nephrol; 2014 Aug; 9(8):1434-40. PubMed ID: 24948143
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gene-gene interactions in APOL1-associated nephropathy.
    Divers J; Palmer ND; Lu L; Langefeld CD; Rocco MV; Hicks PJ; Murea M; Ma L; Bowden DW; Freedman BI
    Nephrol Dial Transplant; 2014 Mar; 29(3):587-94. PubMed ID: 24157943
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association Analysis of the Cubilin (CUBN) and Megalin (LRP2) Genes with ESRD in African Americans.
    Ma J; Guan M; Bowden DW; Ng MCY; Hicks PJ; Lea JP; Ma L; Gao C; Palmer ND; Freedman BI
    Clin J Am Soc Nephrol; 2016 Jun; 11(6):1034-1043. PubMed ID: 27197912
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetics and ESKD Disparities in African Americans.
    Umeukeje EM; Young BA
    Am J Kidney Dis; 2019 Dec; 74(6):811-821. PubMed ID: 31606237
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Missense mutations in the APOL1 gene are highly associated with end stage kidney disease risk previously attributed to the MYH9 gene.
    Tzur S; Rosset S; Shemer R; Yudkovsky G; Selig S; Tarekegn A; Bekele E; Bradman N; Wasser WG; Behar DM; Skorecki K
    Hum Genet; 2010 Sep; 128(3):345-50. PubMed ID: 20635188
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetics of Chronic Kidney Disease Stages Across Ancestries: The PAGE Study.
    Lin BM; Nadkarni GN; Tao R; Graff M; Fornage M; Buyske S; Matise TC; Highland HM; Wilkens LR; Carlson CS; Park SL; Setiawan VW; Ambite JL; Heiss G; Boerwinkle E; Lin DY; Morris AP; Loos RJF; Kooperberg C; North KE; Wassel CL; Franceschini N
    Front Genet; 2019; 10():494. PubMed ID: 31178898
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A null variant in the apolipoprotein L3 gene is associated with non-diabetic nephropathy.
    Skorecki KL; Lee JH; Langefeld CD; Rosset S; Tzur S; Wasser WG; Shemer R; Hawkins GA; Divers J; Parekh RS; Li M; Sampson MG; Kretzler M; Pollak MR; Shah S; Blackler D; Nichols B; Wilmot M; Alper SL; Freedman BI; Friedman DJ
    Nephrol Dial Transplant; 2018 Feb; 33(2):323-330. PubMed ID: 28339911
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Absence of APOL1 risk variants protects against HIV-associated nephropathy in the Ethiopian population.
    Behar DM; Kedem E; Rosset S; Haileselassie Y; Tzur S; Kra-Oz Z; Wasser WG; Shenhar Y; Shahar E; Hassoun G; Maor C; Wolday D; Pollack S; Skorecki K
    Am J Nephrol; 2011; 34(5):452-9. PubMed ID: 21968148
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The first exome wide association study in Tunisia: identification of candidate loci and pathways with biological relevance for type 2 diabetes.
    Dallali H; Boukhalfa W; Kheriji N; Fassatoui M; Jmel H; Hechmi M; Gouiza I; Gharbi M; Kammoun W; Mrad M; Taoueb M; Krir A; Trabelsi H; Bahlous A; Jamoussi H; Messaoud O; Abid A; Kefi R
    Front Endocrinol (Lausanne); 2023; 14():1293124. PubMed ID: 38192426
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic kidney disease: novel insights from genome-wide association studies.
    Böger CA; Heid IM
    Kidney Blood Press Res; 2011; 34(4):225-34. PubMed ID: 21691125
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Apolipoprotein L1 (APOL1) Variants (Vs) a possible link between Heroin-associated Nephropathy (HAN) and HIV-associated Nephropathy (HIVAN).
    Lan X; Rao TK; Chander PN; Skorecki K; Singhal PC
    Front Microbiol; 2015; 6():571. PubMed ID: 26106375
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Urologic care and progression to end-stage kidney disease: a Chronic Kidney Disease in Children (CKiD) nested case-control study.
    Chu DI; Abraham AG; Tasian GE; Denburg MR; Ross ME; Zderic SA; Furth SL
    J Pediatr Urol; 2019 May; 15(3):266.e1-266.e7. PubMed ID: 30962011
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.